Safety and efficacy of capecitabine (C) plus bevacizumab (B) as first-line in metastatic breast cancer

被引：0
|
作者：
Sledge, G.
Miller, K.
Moisa, C.
Gradishar, W.
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
[2] Roche Labs Inc, Nutley, NJ USA
[3] Northwestern Univ, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1013
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a meta-analysis
    Wang Ming
    Zheng Xiaofeng
    Ruan Xiaojiao
    Ye Bailiang
    Cai Long
    Lin Feizhuan
    Tu Jinfu
    Jiang Feizhao
    Li Shaotang
    [J]. CHINESE MEDICAL JOURNAL, 2014, 127 (03) : 538 - 546
  • [22] First-line treatment with bevacizumab plus capecitabine for elderly patients with metastatic colorectal cancer: BECA trial
    Feliu, J.
    Salut, A.
    Safont, M.
    Losa, F.
    Garcia, C.
    Bosch, C.
    Escudero, P.
    Lopez, R.
    Bolanos, M.
    Gonzalez-Baron, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Capecitabine Plus Bevacizumab as First-Line Therapy for Patients with Metastatic Colorectal Cancer and Poor Performance Status
    Yamada, Yasufumi
    Yoshimatsu, Kazuhiko
    Yokomizo, Hajime
    Okayama, Sachiyo
    Satake, Masaya
    Ida, Arika
    Maeda, Hiroyuki
    Shiozawa, Shunichi
    [J]. JOURNAL OF NIPPON MEDICAL SCHOOL, 2021, 88 (05) : 496 - 499
  • [24] PHASE II STUDY OF BEVACIZUMAB plus OXALIPLATIN PLUS CAPECITABINE FOLLOWED BY BEVACIZUMAB plus ERLOTINIB AS FIRST-LINE TREATMENT IN METASTATIC COLORECTAL CANCER
    Munoz, A.
    Pericay, C.
    Llorente, B.
    Alonso, V
    Duenas, R.
    Roca, J.
    Rivera, F.
    Falco, E.
    Alvarez, I
    Salud, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 73 - 74
  • [25] BEVACIZUMAB IN COMBINATION WITH IRINOTECANAND CAPECITABINE AS FIRST-LINE TREATMENT FOR MCRC - EFFICACY AND SAFETY
    Sasa, Jungic
    Gordana, Kecman Malcic
    Ivanka, Rakita
    Dusan, Jovanovic
    Radoslav, Gajanin
    Zdravko, Maric
    Biljana, Tubic
    Zdenka, Gojkovic
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [26] Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer
    M. Degirmenci
    B. Karaca
    G. Gorumlu
    R. Durusoy
    G. Demir Piskin
    M. T. Bozkurt
    Y. Cirak
    D. Tunali
    B. Karabulut
    U. A. Sanli
    R. Uslu
    [J]. Medical Oncology, 2010, 27 : 585 - 591
  • [27] Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer
    Degirmenci, M.
    Karaca, B.
    Gorumlu, G.
    Durusoy, R.
    Piskin, G. Demir
    Bozkurt, M. T.
    Cirak, Y.
    Tunali, D.
    Karabulut, B.
    Sanli, U. A.
    Uslu, R.
    [J]. MEDICAL ONCOLOGY, 2010, 27 (03) : 585 - 591
  • [28] Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer
    Akun, E.
    Okutur, K.
    Seber, S.
    Korkmaz, T.
    Aydin, K.
    Bozkurt, M.
    Namal, E.
    Hasbal, B.
    Tecimer, C.
    Demir, G.
    [J]. JOURNAL OF BUON, 2012, 17 (04): : 669 - 676
  • [29] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    M J Safont
    A Salud
    F Losa
    C García-Girón
    C Bosch
    P Escudero
    R López
    C Madroñal
    M Bolaños
    M Gil
    A Llombart
    J Castro-Carpeño
    M González-Barón
    [J]. British Journal of Cancer, 2010, 102 : 1468 - 1473
  • [30] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    Feliu, J.
    Safont, M. J.
    Salud, A.
    Losa, F.
    Garcia-Giron, C.
    Bosch, C.
    Escudero, P.
    Lopez, R.
    Madronal, C.
    Bolanos, M.
    Gil, M.
    Llombart, A.
    Castro-Carpeno, J.
    Gonzalez-Baron, M.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1468 - 1473
12345